Pharmaron’s drug R&D service offerings cover the full spectrum of drug discovery and development, from discovery through preclinical to clinical development. Once a preclinical candidate is identified in the preclinical development phase, Pharmaron’s clinical development team works closely with our sponsor and regulatory authorities to develop the candidate in clinical trial phases I/II/III and IV by investigating its safety, efficacy, and other clinical end-points.

Our clinical development team is in the US and China, accommodating sponsors with local or international needs to develop their drug candidates for regulatory registrations. We have clinical study experience in numerous medical modalities, including small molecules, large molecules, cell and gene therapy products, and medical devices. Our clinical team has a proven track record in delivering clinical studies for our global sponsors.